Create a 4 page essay paper that discusses Parkinson disease and vitamin D.Even though the research results indicated loss in bone densities for all patients, the patients who received the treatment e

Create a 4 page essay paper that discusses Parkinson disease and vitamin D.

Even though the research results indicated loss in bone densities for all patients, the patients who received the treatment experienced less significant density loss than those who did not receive the vitamin D treatment. This identifies significance of vitamin D in managing loss of bone density, and bone fracture among Parkinson’s disease patients. The article by Chen et all on consumption of dairy products and risk of Parkinson’s disease also develops relevant information on the association between vitamin D and Parkinson’s disease. The researchers clarify that even though the vitamin is a component of dairy products that increases the disease’s incidence, the vitamin does contribute to this relationship. Knowledge of the relationship between Parkinson’s disease and vitamin D is further developed by Kones’ article that identifies a mediation role of the vitamin in bone density and bone fracture among among Parkinson’s disease. Vitamin D facilitates regulation of processes and cells in the brain system and its supplement in Parkinson’s disease patients is associated with significant effects. Amelioration of osteopenia and hupovitaminosis D by 1 ?-hydroxyvitamin D3 in elderly patients with Parkinson disease Reference Sato, Yoshihiro. et al. “Amelioration of osteopenia and hupovitaminosis D by 1 ?-hydroxyvitamin D3 in elderly patients with Parkinson disease.” f Neurol Neurosurg Psychiatry 1996.66 (1996): 64-68. Print. The search used Google search engine with osteoporosis, Parkinson’s disease, as vitamin D, and found multiple resources on the relationship between osteoporosis, Parkinson’s disease, as vitamin D. Sato, Mnabe, Kuno, and Oizumi authored the article that was published by f Neurol Neurosurg Psychiatry. The authors aimed at exploring the relationship between experiences among Parkinson’s disease and vitamin D in the patients and the article notes that despite the identified high prevalence of bone fractures among the patients, there is a knowledge gap on the relationship between bone fracture and the disease. Previous research findings however indicate a relationship between lack of 1, 25-dihydroxyvitamin D among the patients and reduced bone mineral density that is a factor to bone fracture. Inducing forms of vitamin D such as 1a-hydroxyvitamin D3 would therefore manage the density loss in the patients’ bones. This formed the basis of the research. A sample of 86 elderly people was randomly obtained and put into experimental and control groups. The experimental group received 1a-hydroxyvitamin D3 whole the control group remained untreated in the research that took one and a half years before posttest measurement on bone density. Results shows that all Parkinson’s disease patients suffered loss in bone density but those who received 1a-hydroxyvitamin D3 treatment experienced significant lower level of loss compared to patients who were not treated. The disease was also associated with loss of vitamin D elements from the patients’ bodies. Further, eight participants from the control group reported bone fractures while only one from the treatment group reported the fractures, and the research concluded that increasing vitamin D concentration among Parkinson’s disease patients reduces rates of bone fracture that is associated with the disease (Sato, et al., 64- 68).